دورية أكاديمية
أعرض في EDS

Budget impact analysis of a home-based colorectal cancer screening programme in Malaysia.

التفاصيل البيبلوغرافية
العنوان: Budget impact analysis of a home-based colorectal cancer screening programme in Malaysia.
المؤلفون: Ngan TT; Centre for Public Health, Queen's University Belfast, Belfast, UK n.t.tran@qub.ac.uk., Ramanathan K; Global Public Health, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia.; South East Asia Community Observatory, Monash University Malaysia, Selangor, Malaysia., Saleh MRBM; South East Asia Community Observatory, Monash University Malaysia, Selangor, Malaysia., Schliemann D; Centre for Public Health, Queen's University Belfast, Belfast, UK., Ibrahim Tamin NSB; Ministry of Health Malaysia, Putrajaya, Malaysia., Su TT; Global Public Health, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia.; South East Asia Community Observatory, Monash University Malaysia, Selangor, Malaysia., Donnelly M; Centre for Public Health, Queen's University Belfast, Belfast, UK., O'Neill C; Centre for Public Health, Queen's University Belfast, Belfast, UK.
المصدر: BMJ open [BMJ Open] 2023 Mar 21; Vol. 13 (3), pp. e066925. Date of Electronic Publication: 2023 Mar 21.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
مواضيع طبية MeSH: Early Detection of Cancer*/methods , Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/prevention & control, Humans ; Cost-Benefit Analysis ; Malaysia ; Budgets ; Mass Screening/methods
مستخلص: Objectives: The 2020-2022 research project 'Colorectal Cancer Screening Intervention for Malaysia' (CRC-SIM) evaluated the implementation of a home-based CRC screening pilot in Segamat District. This budget impact analysis (BIA) assessed the expected changes in health expenditure of the Malaysian Ministry of Health budget in the scenario where the pilot programme was implemented nationwide vs current opportunistic screening.
Design: Budget impact analysis. Assumptions and costs in the opportunistic and novel CRC screening scenarios were derived from a previous evaluation of opportunistic CRC screening in community health clinics across Malaysia and the CRC-SIM research project, respectively.
Setting: National level (with supplement analysis for district level). The BIA was conducted from the viewpoint of the federal government and estimated the annual financial impact over a period of 5 years.
Results: The total annual cost of the current practice of opportunistic screening was RM1 584 321 (~I$1 099 460) of which 80% (RM1 274 690 or ~I$884 587) was expended on the provision of opportunistic CRC to adults who availed of the service. Regarding the implementation of national CRC screening programme, the net budget impact in the first year was estimated to be RM107 631 959 (~I$74 692 546) and to reach RM148 485 812 (~I$103 043 589) in the fifth year based on an assumed increased uptake of 5% annually. The costs were calculated to be sensitive to the probability of adults who were contactable, eligible and agreeable to participating in the programme.
Conclusions: Results from the BIA provided direct and explicit estimates of the budget changes to when implementing a population-based national CRC screening programme to aid decision making by health services planners and commissioners in Malaysia about whether such programme is affordable within given their budget constraint. The study also illustrates the use and value of the BIA approach in low-income and middle-income countries and resource-constrained settings.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.)
References: BMC Cancer. 2018 Apr 25;18(1):464. (PMID: 29695234)
Pharmacoeconomics. 2001;19(6):609-21. (PMID: 11456210)
J Med Assoc Thai. 2014 May;97 Suppl 5:S65-71. (PMID: 24964701)
Eur J Health Econ. 2011 Dec;12(6):499-502. (PMID: 21874376)
Prz Gastroenterol. 2019;14(2):89-103. (PMID: 31616522)
Pharmacoeconomics. 2009;27(10):807-27. (PMID: 19803537)
BMC Health Serv Res. 2015 Jul 03;15:254. (PMID: 26135302)
Value Health. 1998 Nov;1(4):251-9. (PMID: 16674550)
World J Gastroenterol. 2017 Jul 28;23(28):5086-5096. (PMID: 28811705)
J Med Econ. 2019 Dec;22(12):1351-1361. (PMID: 31560247)
Cancer Epidemiol. 2020 Dec;69:101829. (PMID: 32998070)
Appl Health Econ Health Policy. 2019 Aug;17(4):493-511. (PMID: 31016686)
Asian J Surg. 2017 Nov;40(6):481-489. (PMID: 27492344)
BMJ Open. 2022 Sep 1;12(9):e058420. (PMID: 36581978)
Value Health. 2014 Jan-Feb;17(1):5-14. (PMID: 24438712)
Value Health. 2007 Sep-Oct;10(5):336-47. (PMID: 17888098)
معلومات مُعتمدة: MR/S014349/1 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة: Keywords: HEALTH ECONOMICS; Health policy; ONCOLOGY; PUBLIC HEALTH
تواريخ الأحداث: Date Created: 20230321 Date Completed: 20230323 Latest Revision: 20230816
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10032398
DOI: 10.1136/bmjopen-2022-066925
PMID: 36944471
قاعدة البيانات: MEDLINE
الوصف
تدمد:2044-6055
DOI:10.1136/bmjopen-2022-066925